"We will hit Tundup’s 3300 Patient Years hurdle Nov 1 and see if it triggers anything!!!"

That's not what Tundup wrote. Tundup relayed from his conversation with management that "Should reach 3300 patient years by end of this year." No mention of Nov 1. Importantly, Resverlogix has made no official statement about relevance of an arbitrary number of patient years. No mention of patient year status or importance at the AGM last month. At AGM, it was conveyed that they expect to hit the 250 3-point MACE event mark before year end, at which time they will stop dosing. Subsequently, the adjudication process and safety follow ups will be done with top-line expected Q1 2019. 

BearDownAZ